
The share of biologically active supplements (BAS) in the pharmaceutical market of Uzbekistan is significantly increasing. This was reported by Zamin.uz.
According to an analytical report prepared by DATFO Analytics, as of the end of September 2025, BAS accounted for 9.5 percent of pharmacy sales volume. This figure showed a 1.7-fold increase in monetary value and a 1.4-fold increase in the number of packages compared to 2024.
At the same time, other segments of the pharmaceutical market remain relatively stagnant. The growth of BAS is mainly due to products imported from the United States.
Experts believe that the popularity of biologically active supplements is increasing not through advertising, but due to consumer trust and word-of-mouth recommendations. As a result of rising demand, pharmacy chains have begun actively developing this direction.
Currently, the share of BAS in pharmacy sales is approaching 10 percent, with the average value of one merchandising shelf in Tashkent city being 30-40 US dollars. This situation is turning the BAS segment into one of the most profitable directions in pharmacy sales.
The market leader is the NOW Foods brand. According to DATFO Analytics, NOW Foods plays an important role in developing pharmacy channels and sets standards for the entire category.
Additionally, the Solaray and Solgar brands have strengthened their positions in the premium segment. Solaray's market share reached 1.6 percent, with sales increasing by 93 percent.
Solgar recorded a 67 percent growth with a 1 percent market share. The Swanson brand achieved significant growth in distribution — sales increased by 172 percent, and the number of pharmacies carrying it rose from 118 to 500.
The Childlife brand also expanded its market presence in the children's line. Pharmacy coverage increased from 427 to 1,018, with a market share of 0.56 percent.
The number of pharmacies carrying at least one of the TOP brands grew from 2,226 to 3,429, an increase of 54 percent. Thus, biologically active supplements are no longer a niche product but are becoming a mandatory category in pharmacy assortments (Source: DATFO Analytics).





